Overview The AtriCure ACH150 AtriClip Gillinov-Cosgrove LAA Exclusion System is designed to facilitate the exclusion of the left atrial appendage (LAA) during cardiac procedures. This innovative device aims to reduce the risk of stroke in patients with atrial fibrillation. Intended Use This system is intended for use in patients undergoing cardiac surgery, specifically for the exclusion of the left atrial appendage as part of a comprehensive strategy to manage atrial fibrillation. Specifications
THIS PRODUCT IS EXPIRED AND NOT FOR PATIENT USE
This product/device listed on this page is for Research & Development, Teaching, Testing and other non-clinical uses. If you are looking for products that will be used on a person, please contact the manufacturer. We are not the manufacturer.
The AtriCure ACH150 AtriClip Gillinov-Cosgrove LAA Exclusion System is designed to facilitate the exclusion of the left atrial appendage (LAA) during cardiac procedures. This innovative device aims to reduce the risk of stroke in patients with atrial fibrillation.
Intended Use
This system is intended for use in patients undergoing cardiac surgery, specifically for the exclusion of the left atrial appendage as part of a comprehensive strategy to manage atrial fibrillation.
Specifications
Reference Number: ACH150
Material: N/A
Size: N/A
Sterility
The AtriCure ACH150 AtriClip is provided sterile and is intended for single use only to ensure patient safety and device efficacy.
Regulatory
This product is compliant with FDA and CE regulations, ensuring it meets the highest standards for medical devices.
Package Contents
1 x AtriCure ACH150 AtriClip Gillinov-Cosgrove LAA Exclusion System
Storage
Store in a cool, dry place away from direct sunlight. Ensure that the packaging remains intact until ready for use.